These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 36714420)

  • 1. Retracted: Iopromide and Iodixanol in the Development of Postoperative Contrast Nephropathy in Patients with Renal Insufficiency: A Meta-Analysis.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9864315. PubMed ID: 36714420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iopromide and Iodixanol in the Development of Postoperative Contrast Nephropathy in Patients with Renal Insufficiency: A Meta-Analysis.
    Feng Y; Qiu G; Xu C; Duan Z; Wang M; Wang L; Hu W; Li P; Zhou H
    J Healthc Eng; 2022; 2022():1469370. PubMed ID: 35422982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iodixanol versus iopromide in patients with renal insufficiency undergoing coronary angiography with or without PCI.
    Zhang J; Jiang Y; Rui Q; Chen M; Zhang N; Yang H; Zhou Y
    Medicine (Baltimore); 2018 May; 97(18):e0617. PubMed ID: 29718868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of contrast-induced nephrotoxicity of iodixanol and iopromide in patients with renal insufficiency undergoing coronary angiography.
    Shin DH; Choi DJ; Youn TJ; Yoon CH; Suh JW; Kim KI; Cho YS; Cho GY; Chae IH; Kim CH
    Am J Cardiol; 2011 Jul; 108(2):189-94. PubMed ID: 21545991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety.
    Lenhard DC; Pietsch H; Sieber MA; Ernst R; Lengsfeld P; Ellinghaus P; Jost G
    Invest Radiol; 2012 Sep; 47(9):503-10. PubMed ID: 22864374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant perturbation in renal functional magnetic resonance imaging parameters and contrast retention for iodixanol compared with iopromide: an experimental study using blood-oxygen-level-dependent/diffusion-weighted magnetic resonance imaging and computed tomography in rats.
    Wang YC; Tang A; Chang D; Zhang SJ; Ju S
    Invest Radiol; 2014 Nov; 49(11):699-706. PubMed ID: 24879299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal tolerability of iopromide and iodixanol in 562 renally impaired patients undergoing cardiac catheterisation: the DIRECT study.
    Chen Y; Hu S; Liu Y; Zhao R; Wang L; Fu G; He Q; Su X; Zheng Y; Qi X; Liu H; Wang J; Gao W; Wang M; Liu S; Zheng X; He B; Yang P; Zhou S; Gao C; Qiu C
    EuroIntervention; 2012 Nov; 8(7):830-8. PubMed ID: 23045301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial.
    Juergens CP; Winter JP; Nguyen-Do P; Lo S; French JK; Hallani H; Fernandes C; Jepson N; Leung DY
    Intern Med J; 2009 Jan; 39(1):25-31. PubMed ID: 18771430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up to 50-fold increase in urine viscosity with iso-osmolar contrast media in the rat.
    Seeliger E; Becker K; Ladwig M; Wronski T; Persson PB; Flemming B
    Radiology; 2010 Aug; 256(2):406-14. PubMed ID: 20529990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Iodixanol and Iopromide in Patients With Renal Insufficiency and Congestive Heart Failure Undergoing Coronary Angiography by Hemodynamic Monitoring.
    Qian G; Yang YQ; Dong W; Cao F; Chen YD
    Angiology; 2017 Nov; 68(10):907-913. PubMed ID: 28401790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations.
    Cheruvu B; Henning K; Mulligan J; Klippenstein D; Lawrence D; Gurtoo L; Gottlieb RH
    J Comput Assist Tomogr; 2007; 31(4):493-8. PubMed ID: 17882021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
    Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iodixanol in femoral arteriography (phase III): a comparative double-blind parallel trial between iodixanol and iopromide.
    Pugh ND; Sissons GR; Ruttley MS; Berg KJ; Nossen JO; Eide H
    Clin Radiol; 1993 Feb; 47(2):96-9. PubMed ID: 8435972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between the efficacy of dimeric and monomeric non-ionic contrast media (iodixanol vs iopromide) in urography in patients with mild to moderate renal insufficiency.
    Stacul F; Cova M; Assante M; Hougens Grynne B; Haider T
    Br J Radiol; 1998 Sep; 71(849):918-22. PubMed ID: 10195004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal effects of bicarbonate versus saline infusion for iso- and lowosmolar contrast media in rats.
    Ladwig M; Flemming B; Seeliger E; Sargsyan L; Persson PB
    Invest Radiol; 2011 Nov; 46(11):672-7. PubMed ID: 21623210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of allergic adverse effects and contrast enhancement between iodixanol and iopromide.
    Gharekhanloo F; Torabian S
    Iran J Radiol; 2012 Jun; 9(2):63-6. PubMed ID: 23329965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injection-associated pain in femoral arteriography: a European multicenter study comparing safety, tolerability, and efficacy of iodixanol and iopromide.
    Justesen P; Downes M; Grynne BH; Lang H; Rasch W; Seim E
    Cardiovasc Intervent Radiol; 1997; 20(4):251-6. PubMed ID: 9211770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iodixanol versus iopromide in cancer patients: Evidence from a randomized clinical trial.
    Terrenato I; Sperati F; Musicco F; Pozzi AF; di Turi A; Caterino M; de Lutio di Castelguidone E; Setola SV; Bellomi M; Neumaier CE; Conti L; Cigliana G; Merola R; Antenucci A; Orlandi G; Giordano A; Barba M; Canitano S
    J Cell Physiol; 2018 Mar; 233(3):2572-2580. PubMed ID: 28777459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodixanol versus Iopromide at Coronary CT Angiography: Lumen Opacification and Effect on Heart Rhythm-the Randomized IsoCOR Trial.
    Lubbers MM; Kock M; Niezen A; Galema T; Kofflard M; Bruning T; Kooij HS; van Valen H; Dijkshoorn M; Booij R; Padmos A; Vogels A; Budde RPJ; Nieman K
    Radiology; 2018 Jan; 286(1):71-80. PubMed ID: 28809582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of low-osmolar contrast medium iopromide and iso-osmolar iodixanol on DNA fragmentation in renal tubular cell culture.
    Ludwig U; Connemann J; Keller F
    Clin Exp Nephrol; 2013 Dec; 17(6):779-82. PubMed ID: 23345070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.